Trials / Unknown
UnknownNCT06087094
A Trial of HRS-7450 in Chinese Healthy Volunteers
Randomized, Double-blind, Placebo-controlled, Single-dose Ascending Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7450 in Healthy Subjects.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this First-in-Human study is to evaluate the safety and tolerability after single ascending doses of HRS-7450 given to healthy subjects, compared to placebo..
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7450 ；Placebo | HRS-7450 or Placebo |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-10-17
- Last updated
- 2023-10-17
Source: ClinicalTrials.gov record NCT06087094. Inclusion in this directory is not an endorsement.